Glycaemic variability (GV) predicts the development of chronic micro- and macrovascular conditions and death in people with type 2 diabetes despite good glycaemic control, new Australian research shows. Investigators say the study shows the harmful impact of long-term blood glucose fluctuations and highlights the potential clinical impact of treating GV. The findings are based on ...
Type 2 diabetes
Glycaemic fluctuations predict chronic vascular complications
By Sunalie Silva
20 Aug 2020